Horizons Marijuana Life Sciences Index ETF

Most Recent

  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Do CGC, ACB, TLRY, and APHA Look Cheap?

    With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Markets Rebound but Cannabis Stock Performance Is Mixed

    Markets rebounded today after the recent sell-off fueled by US-China trade tensions.

    By Adam Jones
  • uploads///cannabis _
    Miscellaneous

    Canaccord Genuity Raises Price Target for Canopy Growth

    On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///can_
    Cannabis

    Cannabis Legalization: Four Governors Met in New York

    The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

    By Rajiv Nanjapla
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///c
    Miscellaneous

    Canopy Growth Receives Target Price Upgrades

    Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.

    By Adam Jones
  • uploads///green _
    Company & Industry Overviews

    Tilray Invests in ROSE LifeScience

    On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.

    By Adam Jones
  • uploads///hexo
    Cannabis

    HEXO: Analysts’ Target Price and Ratings

    CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///Canopy_
    Cannabis

    Can Canopy Beat Q2 Estimates and Boost the Sector?

    This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    Cannabis and Vaping Concerns: Will the Dream Go Up in Smoke?

    Cannabis legalization is a vital topic in the US. Meanwhile, vaping related deaths continue to rise. Will vaping concerns kill the US cannabis dream?

    By Sushree Mohanty
  • uploads///mariju
    Cannabis

    Marijuana Vape Products Expected in Alberta Stores

    AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

    By Rajiv Nanjapla
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What to Expect from Its Q4 Results

    Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.

    By Sushree Mohanty
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///marijuana hashish leaf flowerpot
    Cannabis

    Big News: Cannabis Edibles in Alberta Stores

    Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

    By Rajiv Nanjapla
  • uploads///california marijuana future
    Cannabis

    Marijuana Industry: Opportunities in California amid COVID-19

    Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Canada’s Cannabis Act C-45 Makes Progress in the Senate

    On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.

    By Adam Jones
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    Price Target Update for Canopy Growth in January

    Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.

    By Adam Jones
  • uploads///Chart
    Company & Industry Overviews

    MedMen’s Must-Know Revenue Drivers

    MedMen’s (MMNFF) reported revenues are generated from direct sales through its retail stores. The company has reported no material revenues from cultivation or production wholesale operations.

    By Mike Benson
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • Cannabis

    Cannabis 2.0 Legalization: Canada Is Ready

    Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Beverages: Why Canadians Can’t Wait

    Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.

    By Sushree Mohanty
  • uploads///cannabis edibles
    Cannabis

    No Cannabis Edibles in Three Provinces for Christmas

    After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.

    By Sushree Mohanty
  • uploads///cannabsis
    Cannabis

    Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market

    Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

    By Sushree Mohanty
  • uploads///Household Consumption Expenditure on Cannabis
    Company & Industry Overviews

    Why Cannabis Stocks Are on the Rise

    The reason cannabis stocks are rising could be because October 17 is approaching.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Canopy Growth to Get Extract Supply from MediPharm Labs

    On November 29, Canopy Growth (WEED) entered an 18-month supply agreement with MediPharm Labs.

    By Adam Jones
  • uploads/// Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    How Aurora Cannabis’s Valuations Compare to Its Peers’

    On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///marijuana hashish leaf flowerpot
    Earnings Report

    Canopy Growth Reported Its Q1 2019 Results on August 14

    Canopy Growth reported its earnings for the first quarter of 2019 on August 14. The company is one of the largest cannabis producers by capacity.

    By Adam Jones
  • uploads///IIPR
    Basic Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///CGC
    Cannabis

    CGC: How the Future Looks Under Its New CEO

    On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

    By Margaret Patrick
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Is This the Right Time to Invest?

    Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?

    By Sushree Mohanty
  • uploads///Inventory Biological Assets
    Earnings Report

    How Canopy Growth Is Preparing for Legalized Cannabis

    During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.

    By Adam Jones
  • uploads///Aphria
    Cannabis

    Aphria: Analysts’ Target Price and Ratings

    While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Are Its Q4 Results Good or Bad News?

    Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?

    By Sushree Mohanty
  • uploads///Tlry
    Company & Industry Overviews

    Tilray Makes a Bold Prediction on Cannabis Legalization in the US

    Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.

    By Adam Jones
  • uploads///marijuanaI
    Cannabis

    New Year Will Bring Legal Marijuana to Illinois Residents

    Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Raymond James Foresees a Cannabis Rebound in 2020

    Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]

    By Sushree Mohanty
  • uploads///seedling _
    Company & Industry Overviews

    The Market Is Sinking and Taking the Cannabis Sector Along

    This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Why Tilray Cannabis Stock Popped Today

    On September 18, cannabis stock Tilray (TLRY) popped about 27% to an all-time high of $153.8 in the mid-day session.

    By Adam Jones
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What’s the Word on the Street?

    Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///ACB_
    Cannabis

    Aurora Cannabis Releases Update on Cannabis 2.0

    Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    What’s the Market Potential for CBD?

    The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

    By Margaret Patrick
  • uploads///marijuana _
    Company & Industry Overviews

    Key Developments in the Cannabis Sector Last Week

    The week ending February 16 wasn’t so positive for marijuana stocks even though the broader market indexes ended in the positive territory.

    By Adam Jones
  • uploads///cannabis
    Company & Industry Overviews

    Cannabis Stocks: Will Tough Times End Soon?

    Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

    By Sushree Mohanty
  • uploads///mexico
    Cannabis

    Will Mexico Legalize Cannabis by the End of the Month?

    With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

    By Rajiv Nanjapla
  • uploads///medmen recovery
    Cannabis

    Did MedMen’s Q3 Earnings Start a Path to Recovery?

    MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.

    By Sushree Mohanty
  • uploads///cannabis sector pitfalls
    Cannabis

    Coronavirus Revealed Cannabis Supply Chain’s Pitfalls

    The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain. 

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Regulators Beware: Cannabis Linked to Job Loss

    Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.

    By Sushree Mohanty
  • uploads///PLTH_
    Company & Industry Overviews

    Planet 13 Inks Deal with Mike Tyson’s Cannabis Venture

    Today, Planet 13 Holdings (PNTH) (PLNHF) announced that it had inked a purchase agreement with Tyson Ranch, which is owned by boxer Mike Tyson.

    By Rajiv Nanjapla
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    Cannabis Legalization: Dark Clouds Loom Post Debate

    Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

    By Sushree Mohanty
  • uploads///marijuana _
    Miscellaneous

    MedReleaf Stock Rises on Aurora Cannabis Acquisition

    Today, Aurora Cannabis (ACB)(ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars.

    By Adam Jones
  • uploads///log _
    Company & Industry Overviews

    Canopy Growth Moves to Acquire Hiku Brands Company

    On July 10, Canopy Growth (WEED) (CGC) announced that it had entered an agreement to acquire Hiku Brands Company (HIKU).

    By Adam Jones
  • uploads///marijuana fed reserve bank
    Cannabis

    Marijuana Legalization Catches Federal Reserve Bank’s Attention

    The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Raymond James Is Cautiously Optimistic about Cannabis Stocks

    So far, cannabis stocks have rebounded in 2020, which investors expected. The marijuana industry struggled in 2019. Overall, the rebound will take time.

    By Sushree Mohanty
  • uploads///Jim Cramer
    Cannabis

    Why Does Jim Cramer Like Cronos Group and Aphria?

    Cronos Group and Aphria are Jim Cramer’s top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors’ faith in the sector.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Corruption in the US: Trouble before Elections?

    Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?

    On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.

    By Rajiv Nanjapla
  • uploads///Cannabis ETF Daily Performance
    Company & Industry Overviews

    Is Aurora Cannabis Looking at a Consumer Business Acquisition?

    Since Peltz has experience in the consumer market space, Aurora Cannabis is probably looking to make a deeper foray into the consumer space.

    By Adam Jones
  • uploads///Marijuana
    Cannabis

    Marijuana Sales Soar amid Coronavirus Pandemic

    Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.

    By Sushree Mohanty
  • uploads///acreage holdings analysts
    Cannabis

    Acreage Holdings: Analysts Weren’t Pleased after Disappointing Q1

    Investors and analysts weren’t pleased with Acreage Holdings’ (OTCMKTS:ACRGF) results for the first quarter of 2020. The company posted another EBITDA loss.

    By Sushree Mohanty
  • uploads///cronos group raymond james bullish
    Cannabis

    Why Is Raymond James Bullish on Cronos Group?

    Earlier this week, Rahul Sarugaser of Raymond James upgraded Cronos Group (NASDAQ:CRON) from “market perform” to “outperform.”

    By Rajiv Nanjapla
  • uploads///aurora cannabis analysts bullish
    Cannabis

    Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish

    Aurora Cannabis (NYSE:ACB) announced some business transformation plans on June 23. The plans included cost savings and margin improvement.

    By Sushree Mohanty
  • uploads///aurora cannabis aphria cantor fitzgerald
    Cannabis

    Aurora Cannabis Announces Job Cuts and Facility Closures

    On Tuesday, Aurora Cannabis (NYSE:ACB) provided an update on its business transformation plan, which it announced earlier this year.

    By Rajiv Nanjapla
  • uploads///cannabis top  stocks
    Cannabis

    Why Canadian Cannabis Sales Dipped Slightly in April

    In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Why HEXO Stock Tanked More than 11% on Wednesday

    On Wednesday, HEXO announced a new at-the-market equity program, which would allow it to issue common shares worth up to 34.5 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///charlottes web abacus health
    Cannabis

    Will the Abacus Health Acquisition Benefit Charlotte’s Web?

    On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.

    By Sushree Mohanty
  • uploads///OrganiGram_
    Cannabis

    OrganiGram Stock Rose Due to New International Agreement

    On Wednesday, OrganiGram Holdings (NASDAQ:OGI) announced that its subsidiary OrganiGram signed a supply agreement with Canndoc.

    By Rajiv Nanjapla
  • uploads///green thumb industries
    Cannabis

    Green Thumb Industries Opens Its 46th Retail Store

    On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.

    By Rajiv Nanjapla
  • uploads///canopy growth cannabis
    Cannabis

    Is Canopy Growth a ‘Buy’ after Its Recent Pullback?

    Since Canopy Growth (NYSE:CGC)(TSE:WEED) reported its results for the fourth quarter of fiscal 2020, it has lost 22.4% of its stock value as of Tuesday.

    By Rajiv Nanjapla
  • uploads///Jim Cramer
    Cannabis

    Why Is HEXO Rising before Its Q3 Earnings?

    HEXO (TSE:HEXO) will likely report its third-quarter earnings before the market opens on June 11. So far, HEXO has lost 58.9% of its stock value this year.

    By Rajiv Nanjapla
  • uploads///aurora cannabis q results announce
    Cannabis

    Aurora Cannabis Continues to Shine: Should You Book Profits?

    As of June 5, Aurora Cannabis was trading at 18.79 Canadian dollars—a rise of 104.2% since it reported its third-quarter earnings.

    By Rajiv Nanjapla
  • uploads///cigarette and cannabis sales
    Cannabis

    How’s COVID-19 Impacting Cigarette and Cannabis Sales?

    Layoffs amid COVID-19 led to a decline in disposable income, which had a negative impact on the cigarette and cannabis industries.

    By Rajiv Nanjapla
  • uploads///curaleaf
    Consumer

    Why Does Paradigm Capital Favor OrganiGram Holdings?

    Paradigm Capital analyst Corey Hammill is bullish on OrganiGram. He rated the stock as a “buy” with a target price of 4.00 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    HEXO Launches New Tsunami Format, Targets Medical Customers

    On Wednesday, HEXO launched its high-THC strain Tsunami in a new 30-gram pack exclusively for medical usage. The launch impressed investors.

    By Rajiv Nanjapla
  • uploads///Acb_
    Cannabis

    Analysts Are Bearish after Canopy Growth’s Weak Q4 Earnings

    Canopy Growth (NYSE:CGC)(TSE:WEED) reported its fourth-quarter earnings before the market opened on May 29. The company’s earnings were weak.

    By Rajiv Nanjapla
  • uploads///Cresco Labs
    Cannabis

    HEXO Received License Amendment, Stock Rose Monday

    On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario.

    By Rajiv Nanjapla
  • uploads///Jamaica
    Cannabis

    Why Are Canadian Cannabis Companies Leaving Jamaica?

    Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.

    By Rajiv Nanjapla
  • uploads///OGI_
    Cannabis

    Why Is Raymond James Bullish on OrganiGram?

    Rahul Sarugaser of Raymond James is upbeat on OrganiGram Holdings (NASDAQ:OGI). The company amended its credit facility with the Bank of Montreal.

    By Rajiv Nanjapla
  • uploads///aurora cannabis q results announce
    Cannabis

    Why Analysts Still Aren’t Convinced about Aurora Cannabis

    Since Aurora Cannabis reported its third-quarter earnings, Piper Sandler upgraded the stock from “underweight” to “neutral.” Analysts favor a “hold” rating.

    By Rajiv Nanjapla
  • uploads///aphria mixed reactions
    Cannabis

    Why Analysts Had Mixed Reactions to Aphria’s Q3 Earnings

    On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///canopy growth aurora cannabis
    Cannabis

    Comparing Canopy Growth and Aurora Cannabis’s Valuation Multiples

    Canopy Growth and Aurora Cannabis are two prominent players in the cannabis sector. So far in 2020, Canopy Growth has outperformed cannabis ETFs.

    By Rajiv Nanjapla
  • uploads///Aphria_
    Cannabis

    Will Aphria’s Q3 Earnings Lift the Cannabis Sector?

    Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.

    By Rajiv Nanjapla
  • uploads///weed cron coronavirus
    Cannabis

    Bruce Linton: WEED and CRON Can Handle COVID-19 Storm

    On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.

    By Rajiv Nanjapla
  • uploads///marijuana stocks april
    Cannabis

    What Can You Expect from Marijuana Stocks in April?

    As of April 3, Aurora Cannabis stock has fallen 10%, while Canopy Growth has fallen 8.1%. Cronos Group and Hexo have fallen 2.6% and 19.3% in April.

    By Sushree Mohanty
  • uploads///organigram and aphria compare
    Cannabis

    Comparing OrganiGram and Aphria’s Valuation Multiples

    So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.

    By Rajiv Nanjapla
  • uploads///cannabis stocks future
    Cannabis

    3 Cannabis Stocks Investors Should Watch as Markets Rebound

    As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

    By Rajiv Nanjapla
  • uploads///marijuana federal aid
    Cannabis

    Coronavirus: Marijuana Industry Asks for Federal Business Relief

    Currently, the cannabis industry has pleaded with the federal government to help cannabis businesses during these distressing times.

    By Sushree Mohanty
  • uploads///cannabis stocks broader market
    Cannabis

    Cannabis Stocks Outperformed Broader Equity Markets Last Week

    Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.

    By Rajiv Nanjapla
  • uploads///Aphria_OGI
    Cannabis

    Why Did Bank of America Upgrade Aphria and OrganiGram?

    On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.

    By Rajiv Nanjapla
  • uploads///curaleaf beat expectations
    Cannabis

    Will Curaleaf Beat Analysts’ Expectations in Q4?

    Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

    By Rajiv Nanjapla
  • uploads///CWEB_
    Cannabis

    What to Expect from Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating

    On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Will the Fed’s Rate Cut Help Marijuana Stocks?

    The marijuana sector saw a sharp decline last week amid the global sell-off. The S&P 500 fell by 8.8% in the week ending on March 13.

    By Rajiv Nanjapla
  • uploads///curaleaf upcoming results
    Cannabis

    Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings

    As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”

    By Rajiv Nanjapla
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.